SCNI: Scinai Immunotherapeutics O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati

Scinai Immunotherapeutics (SCNI) tovar belgisi

Scinai Immunotherapeutics patentlar bilan himoyalangan, yallig'lanishga qarshi kurashish uchun noyob nanoantitelalarni ishlab chiqadi. Biznes o'zining monopol maqomi va Quddus laboratoriyalarining GMP sertifikatiga tayanadi. PEG koeffitsiyenti tarixi baholash dinamikasini aks ettiradi, bunda joriy holat 0.00 hisoblanadi. Yetakchi immunologlar avtoimmun patologiyalar terapiyasi uchun eng zamonaviy R&D moliyalashtirish imkoniyatlaridan foydalangan holda loyihaning rivojlanishini boshqarmoqdalar.

SCNI Scinai: Narxning foydaga va o‘sish sur’atiga nisbati 21.02.2024 - 16.11.2026 oraligʻida

Scinai (SCNI) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:SCNI - BiondVax Pharmaceuticals
Scinai Immunotherapeutics Ltd brend mahsuloti

PEG koeffitsiyenti joriy P/E ko'paytirgichini foyda o'sish sur'atlari bilan solishtirib, biznes kengayish dinamikasi aksiyalarning bozor qiymatini oqlash-oklamasligini aniqlaydi. Baholash va o'sish o'rtasidagi muvozanatning ushbu ko'rsatkichi tahlil qilinganda, investor Scinai Immunotherapeutics (SCNI) kompaniyasining salohiyatini nano-antitelolarni tijoratlashtirish va psoriaz terapiyasi bo'yicha klinik sinovlardagi muvaffaqiyatlar prizmasi orqali baholashi mumkin.

Scinai Immunotherapeutics raqobatchilari

ARGX (Argenx) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (biontech.de)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax S.A. (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|Protagonist Therapeutics, Inc. (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant Therapeutics (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori adaptivebiotech.com|Narxning foydaga va o‘sish sur’atiga nisbati Celldex (CLDX)|Aurinia Pharmaceuticals Inc. - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (biocryst.com)|Vera Therapeutics, Inc. (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Therapeutics, Inc. - PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati PHVS|ABCL: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Tourmaline Corp (TRML)|PGEN (precigen.com) - PEG multiplikatori|PEG multiplikatori Pharming Corp|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|UPB (Upstream Bio Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Bio ZBIO|IMNM: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|GOSS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati KalVista Pharmaceuticals KALV|Septerna (SEPN) - Narxning foydaga va o‘sish sur’atiga nisbati|pieris.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|SVRA (Savara Inc) - PEG multiplikatori|RIGL: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ANAB|ATXS (Astria Pharma) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati enGene Holdings Inc. ENGN|PEG multiplikatori RAPT Therapeutics Inc. RAPT|Aerovate Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Aclaris Therapeutics Inc.|Kyverna (KYTX) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Tiziana Life Sciences (TLSA)|Narxning foydaga va o‘sish sur’atiga nisbati Cabaletta Bio Inc.|Ventyx Biosciences (VTYX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori THTX|PEG multiplikatori Avalo Therapeutics Inc. (AVTX)|PEG multiplikatori ELDN (eledon.com)|AGEN - Narx-foyda va o‘sish multiplikatori|CLYM: Narx-foyda va o‘sish multiplikatori|ZURA (Zura Bio Limited) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ATYR: PEG multiplikatori|Adagene (ADAG) - PEG multiplikatori|IMA (ikenaoncology.com) - PEG multiplikatori|shattucklabs.com (STTK) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Equillium Inc (EQ)|Connect Pharma - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Immunic, Inc. IMUX|ATRA - Narx-foyda va o‘sish multiplikatori|IFRX - Narxning foydaga va o‘sish sur’atiga nisbati|XFOR: Narxning foydaga va o‘sish sur’atiga nisbati|ACET: PEG multiplikatori|Celularity Corp (CELU) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati INmune Bio|Barinthus Biotherapeutics plc (BRNS) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori KZR|SABS: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori AKTX (Akari Therapeutics, Plc)|ENLV (Enlivex Therapeutics, Ltd.) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|QTTB: Narx-foyda va o‘sish multiplikatori|GOVX - PEG multiplikatori|Edesa Biotech Corp (EDSA) - Narxning foydaga va o‘sish sur’atiga nisbati|IBIO - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati carismatx.com|XTLB: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Bolt Biotherapeutics Inc. (BOLT)|HCWB (HCW Biologics) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Aptevo Therapeutics - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori AIM ImmunoTech Inc. AIM|Aditxt Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti GRI (GRI Bio, Inc.)|XORTX Therapeutics Inc (XRTX) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori ReShape Lifesciences|Narx-foyda va o‘sish multiplikatori REVB|Indaptus Corp (INDP) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori CALI|Narx-foyda va o‘sish multiplikatori Affimed N.V. AFMD|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati iTeos Therapeutics ITOS|Ocean Biomedical (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|tcbiopharm.com (TCBP) - PEG multiplikatori|THRD (Third Harmonic Bio Inc.) - PEG multiplikatori